TY - JOUR
T1 - Editorial: Revisiting the Metastatic Cascade-Putting Myeloid Cells Into Context
AU - Filippou, Panagiota S.
AU - Karagiannis, George S.
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2020/12/23
Y1 - 2020/12/23
N2 - In the tumor microenvironment, there is a wide variety of non-tumor cells, including immune cells, which participate in reciprocal interactions with tumor cells to promote the acquisition of critical cancer hallmarks (1, 2). In hematopoiesis, immune cells of the myeloid lineage arise from the common myeloid progenitor, also known as “myeloid stem cell”. Myeloid cells represent a proponent compartment of the tumor microenvironment, and comprise both terminally-differentiated cells (such as macrophages, neutrophils, eosinophils, basophils, mast cells) and more immature or undifferentiated subsets (such as monocytes), among others (3). This Research Topic focuses on novel mechanistic insights on the intricate role of myeloid cells in cancer metastasis and highlights translational and clinical opportunities.
AB - In the tumor microenvironment, there is a wide variety of non-tumor cells, including immune cells, which participate in reciprocal interactions with tumor cells to promote the acquisition of critical cancer hallmarks (1, 2). In hematopoiesis, immune cells of the myeloid lineage arise from the common myeloid progenitor, also known as “myeloid stem cell”. Myeloid cells represent a proponent compartment of the tumor microenvironment, and comprise both terminally-differentiated cells (such as macrophages, neutrophils, eosinophils, basophils, mast cells) and more immature or undifferentiated subsets (such as monocytes), among others (3). This Research Topic focuses on novel mechanistic insights on the intricate role of myeloid cells in cancer metastasis and highlights translational and clinical opportunities.
UR - http://www.scopus.com/inward/record.url?scp=85099136365&partnerID=8YFLogxK
U2 - 10.3389/fonc.2020.631278
DO - 10.3389/fonc.2020.631278
M3 - Editorial
AN - SCOPUS:85099136365
SN - 2234-943X
VL - 10
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 631278
ER -